Braidwell LP Xenon Pharmaceuticals Inc. Transaction History
Braidwell LP
- $1.63 Billion
- Q2 2025
A detailed history of Braidwell LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Braidwell LP holds 3,605,029 shares of XENE stock, worth $130 Million. This represents 6.91% of its overall portfolio holdings.
Number of Shares
3,605,029
Previous 2,709,875
33.03%
Holding current value
$130 Million
Previous $90.9 Million
24.11%
% of portfolio
6.91%
Previous 5.58%
Shares
11 transactions
Others Institutions Holding XENE
# of Institutions
220Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$194 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$156 Million1.31% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$129 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$115 Million0.02% of portfolio
-
Commodore Capital LP New York, NY3.03MShares$109 Million8.83% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.24B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...